Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02478502
What this trial is testing

Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer

Who this might be right for
Testicular Cancer
University Hospital, Akershus 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03719131
What this trial is testing

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVStage III Melanoma+5 more
Emory University 15
Early research (Phase 1)Ended earlyNCT02530502
What this trial is testing

Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Adult Glioblastoma
Northwestern University 4
Not applicableStudy completedNCT01121419
What this trial is testing

The Role of IMP3 Expression in Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
National Taiwan University Hospital
Not applicableUnknownNCT02581228
What this trial is testing

Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy

Who this might be right for
Melanoma
Optimata Ltd. 500
Early research (Phase 1)Looking for participantsNCT05879367
What this trial is testing

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme+4 more
Orbus Therapeutics, Inc. 66
Not applicableLooking for participantsNCT06206707
What this trial is testing

FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis

Who this might be right for
DiarrheaColitisMalignant Melanoma+1 more
University of Aarhus 20
Testing effectiveness (Phase 2)Study completedNCT01301430
What this trial is testing

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme
Oryx GmbH & Co. KG 18
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Testing effectiveness (Phase 2)UnknownNCT04822805
What this trial is testing

Anlotinib in the Treatment of Recurrent High-grade Glioma

Who this might be right for
Recurrent High-grade Glioma
First People's Hospital of Hangzhou 27
Large-scale testing (Phase 3)Looking for participantsNCT06809322
What this trial is testing

Vorasidenib Maintenance for IDH Mutant Astrocytoma

Who this might be right for
IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC 468
Testing effectiveness (Phase 2)Study completedNCT02697630
What this trial is testing

Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye

Who this might be right for
Metastatic Uveal Melanoma
Vastra Gotaland Region 29
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableActive Not RecruitingNCT05488483
What this trial is testing

Tumor Imaging With Multispectral Optoacoustic Tomography

Who this might be right for
Breast CancerMelanoma
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Study completedNCT01208454
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Post-approval studies (Phase 4)UnknownNCT01424839
What this trial is testing

Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors

Who this might be right for
Intracranial Germ Cell Tumors
University Hospital Muenster 400
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Not applicableLooking for participantsNCT07831772
What this trial is testing

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor
University of Minnesota 4
Next Page